Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease

. Background. Unstable coronary artery disease (CAD) is a multi‐factorial disease involving thrombotic and inflammatory processes. Short‐term low molecular weight (LMW) heparin treatment reduces coagulation activity and clinical events. We investigated the influence of prolonged treatment on coagulation, fibrinolysis and inflammation. Methods and results. Serial blood samples were obtained from 555 of 2267 unstable CAD patients in the FRISC II...